These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 38539537)
1. Transforming Growth Factor Beta 2 (TGFB2) mRNA Levels, in Conjunction with Interferon-Gamma Receptor Activation of Interferon Regulatory Factor 5 (IRF5) and Expression of CD276/B7-H3, Are Therapeutically Targetable Negative Prognostic Markers in Low-Grade Gliomas. Trieu V; Maida AE; Qazi S Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539537 [TBL] [Abstract][Full Text] [Related]
2. Transforming Growth Factor Beta 2 (TGFB2) and Interferon Gamma Receptor 2 (IFNGR2) mRNA Levels in the Brainstem Tumor Microenvironment (TME) Significantly Impact Overall Survival in Pediatric DMG Patients. Qazi S; Talebi Z; Trieu V Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255296 [TBL] [Abstract][Full Text] [Related]
3. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas. Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009 [TBL] [Abstract][Full Text] [Related]
4. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma. Wang Z; Wang Z; Zhang C; Liu X; Li G; Liu S; Sun L; Liang J; Hu H; Liu Y; Zhang W; Jiang T Cancer Sci; 2018 Sep; 109(9):2697-2705. PubMed ID: 30027617 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of the prognostic and role in immune cell infiltration of MSR1 expression in lower-grade gliomas. Ji Q; Huang K; Jiang Y; Lei K; Tu Z; Luo H; Zhu X Cancer Med; 2022 May; 11(9):2020-2035. PubMed ID: 35142109 [TBL] [Abstract][Full Text] [Related]
6. 1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas. Zhang Y; Xie Y; He L; Tang J; He Q; Cao Q; Cui L; Guo W; Hua K; Dimberg A; Wang L; Zhang L Cell Oncol (Dordr); 2021 Feb; 44(1):193-204. PubMed ID: 32915415 [TBL] [Abstract][Full Text] [Related]
7. Identification of RUNX1 and IFNGR2 as prognostic-related biomarkers correlated with immune infiltration and subtype differentiation of low-grade glioma. Zhang X; Chu H; Cheng Y; Ren J; Wang W; Liu X; Yan X Biomol Biomed; 2023 May; 23(3):405-425. PubMed ID: 36321611 [TBL] [Abstract][Full Text] [Related]
8. A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma. Xiao Y; Cui G; Ren X; Hao J; Zhang Y; Yang X; Wang Z; Zhu X; Wang H; Hao C; Duan H Front Oncol; 2020; 10():605737. PubMed ID: 33381460 [TBL] [Abstract][Full Text] [Related]
9. B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy. Chen S; Zhan S; Ding S; Zhang Q; Xuan H; Zhang X; Cao L J Cancer Res Clin Oncol; 2023 Dec; 149(18):16609-16621. PubMed ID: 37715830 [TBL] [Abstract][Full Text] [Related]
10. IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas. Zhang L; He L; Lugano R; Roodakker K; Bergqvist M; Smits A; Dimberg A Neuro Oncol; 2018 Oct; 20(11):1505-1516. PubMed ID: 29846705 [TBL] [Abstract][Full Text] [Related]
11. PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma. Zhi W; Wang Y; Jiang C; Gong Y; Chen Q; Mao X; Deng W; Zhao S Front Immunol; 2023; 14():1128244. PubMed ID: 37818357 [TBL] [Abstract][Full Text] [Related]
12. Analysis of interferon-γ receptor IFNGR1 and IFNGR2 expression and regulation at the maternal-conceptus interface and the role of interferon-γ on endometrial expression of interferon signaling molecules during early pregnancy in pigs. Yoo I; Seo H; Choi Y; Jang H; Han J; Lee S; Choi Y; Ka H Mol Reprod Dev; 2019 Dec; 86(12):1993-2004. PubMed ID: 31680343 [TBL] [Abstract][Full Text] [Related]
13. High STAT1 mRNA levels but not its tyrosine phosphorylation are associated with macrophage infiltration and bad prognosis in breast cancer. Tymoszuk P; Charoentong P; Hackl H; Spilka R; Müller-Holzner E; Trajanoski Z; Obrist P; Revillion F; Peyrat JP; Fiegl H; Doppler W BMC Cancer; 2014 Apr; 14():257. PubMed ID: 24725474 [TBL] [Abstract][Full Text] [Related]
14. CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment. Wang F; Tao Z; Tian Z; Jin J; Dong J; Dai Y; Yu W; Tang B; Hu S Front Genet; 2022; 13():874896. PubMed ID: 35865011 [No Abstract] [Full Text] [Related]
15. Clinical Management and Therapeutic Strategies for the Thyroid-Associated Ophthalmopathy: Current and Future Perspectives. Mishra S; Maurya VK; Kumar S; Ankita ; Kaur A; Saxena SK Curr Eye Res; 2020 Nov; 45(11):1325-1341. PubMed ID: 32567373 [TBL] [Abstract][Full Text] [Related]
16. Systemic screening identifies GABRD, a subunit gene of GABAA receptor as a prognostic marker in adult IDH wild-type diffuse low-grade glioma. Zhang H; Zhang L; Tang Y; Wang C; Chen Y; Shu J; Zhang K Biomed Pharmacother; 2019 Oct; 118():109215. PubMed ID: 31545245 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of the canonical signaling pathway of interferon-gamma is associated with glioblastoma progression. Zamora-Salas SX; Macías-Silva M; Tecalco-Cruz AC Mol Biol Rep; 2024 Jan; 51(1):64. PubMed ID: 38170343 [TBL] [Abstract][Full Text] [Related]
18. Phospholipase Cγ1 (PLCG1) overexpression is associated with tumor growth and poor survival in IDH wild-type lower-grade gliomas in adult patients. Li T; Yang Z; Li H; Zhu J; Wang Y; Tang Q; Shi Z Lab Invest; 2022 Feb; 102(2):143-153. PubMed ID: 34697421 [TBL] [Abstract][Full Text] [Related]
19. Expression of interferon-γ, interferon-α and related genes in individuals with Down syndrome and periodontitis. Tanaka MH; Giro EM; Cavalcante LB; Pires JR; Apponi LH; Valentini SR; Spolidório DM; Capela MV; Rossa C; Scarel-Caminaga RM Cytokine; 2012 Dec; 60(3):875-81. PubMed ID: 22995210 [TBL] [Abstract][Full Text] [Related]
20. Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas. Huang W; Wu Y; Zhu J; Luo N; Wang C; Liu S; Cheng Z Front Mol Biosci; 2023; 10():963639. PubMed ID: 36825202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]